Disruption of the circadian rhythm is now believed to associate with a number of hormone-related cancers, such as breast cancer, in which aberrant estrogen receptor-a (ERa) signaling is a major contributor. However, the molecular mechanisms underlying the function of core clock proteins in cancer are still largely undefined. In this study, we showed that circadian locomotor output cycles kaput (CLOCK), a key circadian protein, can interact with ERa. Furthermore, this interaction was enhanced by estrogen. We also showed that CLOCK can be sumoylated and sumoylation of CLOCK, which is also stimulated by estrogen, had two consequences: (1) it increased the transcriptional activity of CLOCK; and (2) it increased the CLOCK-modulated transcriptional activity of ERa, as shown by increased transcription of cyclin D1. Sumoylation of CLOCK occurred at two lysine residues, K67 and K851. The enhancement of ERa transcriptional activity exerted by wild-type but not mutant (2K/2R) CLOCK in response to estrogen indicated that sumoylation of CLOCK may have an important role in estrogen-dependent signaling. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay conducted with breast cancer cell lines (MCF-7 and T47D) demonstrated that sumoylation of CLOCK stimulated cell growth and increased the proportion of S phase cells in the cell cycle. The results of this study uncovered new insight into the connection between a major circadian protein and a major estrogen-dependent transcription factor, providing the basis for further research into the involvement of circadian proteins in breast cancer.
INTRODUCTION
The steroid hormone estrogen (E2) is essential for normal mammary gland physiology, and a potent mammary mitogen. 1, 2 The main mechanism by which E2 regulates gene transcription is through binding with estrogen receptors (ERs), which then form a dimer and bind to estrogen-responsive elements (EREs) in the regulatory regions of downstream target genes and associate with basal transcription factors, coactivators or corepressors to regulate the expressions of these genes. [2] [3] [4] There are two isoforms of ERs, ERa and ERb, and both are known to modulate the expressions of genes that are implicated in different cellular processes, including tumorigenesis. 5, 6 Much investigation has focused on understanding the role of ERa in the development and progression of breast cancer, and it has been shown that aberrant ERa signaling is closely related to the occurrence of ERa-positive breast cancer. 7 ERa has been shown to interact with several coactivators having histone acetyltransferase activity, including cAMP-response element binding protein (CREB)-binding protein, p300, and members of the p160 family, such as steroid receptor coactivator-1 (SRC-1), SRC-2 and SRC-3. 8, 9 The transcriptional activities of all members of the p160 family are regulated by their post-translational modifications, such as phosphorylation and sumoylation. [10] [11] [12] [13] The secretions of endocrine and metabolic hormones occur in a rhythmical manner. Reciprocally circulating levels of these hormones influence the circadian rhythms. Disruption of this communication has a profound effect on human health and has been linked to diverse pathological conditions, including hormonerelated breast and endometrial cancers. 14, 15 A remarkable example is that overnight-shift workers tend to have an increased incidence of hormone-related breast cancer as well as other types of malignancies. 15, 16 In addition to epidemiological studies showing a clear connection between disruption of circadian rhythms and breast cancers, numerous studies have also reported that the expression levels of the period (Per1 and Per2) genes in both sporadic and familial primary breast tumor tissues are significantly lower compared with the levels in normal breast tissues. [17] [18] [19] Most physiological processes in mammals are influenced by circadian rhythms. The mechanism of circadian oscillation is generated by a cell autoregulatory transcription-translation feedback loop. At the molecular levels, circadian rhythm is composed of a set of interlocked clock proteins in which circadian locomotor output cycles kaput (CLOCK) and brain and muscle ARNT-like protein 1 (BMAL1) are the core circadian proteins. CLOCK and BMAL1 can associate with each other to form heterodimer, which then bind to E-box elements in the promoters of target genes to induce the rhythmical transcription of period (Per1, 2 and 3) and cryptochrome (Cry1 and 2) in the positive limb. [20] [21] [22] CLOCK has an intrinsic histone acetyltransferase activity, so it can initiate chromatin remodeling and create a favorable state for transcription. 23 The transcripts of Per and Cry genes are then translated into their corresponding proteins, PERs and CRYs, in the cytoplasm. PERs and CRYs form heterodimers and are subsequently transported into the nucleus where they can function as potent inhibitors of CLOCK-BMAL1-driven transcription. [24] [25] [26] To start a new cycle, the inhibition of CLOCK-BMAL1 heterodimer has to be released by the proteolytic degradation of PER and CRY. and chromatin remodeling, which are pivotal to maintaining the circadian rhythms.
At present, few studies have focused on the post-translational modification of CLOCK other than its phosphorylation by protein kinase C and glycogen synthase kinase-3. 27, 28 Small ubiquitin like-modifier (SUMO) modification is an important mechanism for dynamical post-translation regulation of protein functions. 29 To our knowledge, there has been no report concerning the sumoylation of circadian proteins, except for BMAL1 and differentiated embryo-chondrocyte expressed gene1 (DEC1). 30, 31 Both BMAL1 and members of the p160 family transcription coactivator, which have similar structure with CLOCK, have all been shown to be sumoylated, so we speculated that CLOCK may also be subjected to sumoylation.
Although a growing number of studies have suggested that disruption of the circadian rhythm is associated with breast tumorigenesis, very few studies have investigated the direct involvement of circadian proteins in the estrogen signaling pathway. PER2 expression is now known to be induced by estrogen, and PER2 can bind to ERa and enhance its degradation, linking the circadian rhythm to ERa signaling pathway.
14 CLOCK shares a number of structural features with p160 family proteins, which are classical coactivators of ERa, including a highly conserved basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) domain, nuclear receptor interaction domain and a glutaminerich C-terminal domain that possesses histone acetyltransferase activity. 23 Based on the structural similarity between CLOCK and p160 family proteins, we proposed that CLOCK could well be a potential cofactor of ERa.
In this study, we showed that CLOCK can associate with ERa to enhance the transcriptional activity of ERa, and this was promoted by E2. We also showed that CLOCK could be sumoylated and identified two sumoylation sites. Sumoylation of CLOCK enhanced its transcriptional activity and interaction with ERa, resulting in upregulation of ERa activity. Our data have given new insight into the involvement of CLOCK in estrogen signaling pathway, with ERa as its key interacting transcription factor. RESULT E2 promotes the association of CLOCK with ERa As CLOCK shares a similar structure with members of p160 family (Figure 2c ), all of which are all classical coactivators of ERa, the possibility of CLOCK interacting with ERa was investigated in the breast cancer cell line MCF-7, without and with E2 stimulation. Co-immunoprecipitation experiments showed that CLOCK associated with ERa in MCF-7 cells, and this interaction was enhanced by treatment of the cells with E2 before immunoprecipitation ( Figure 1a) . Similar co-precipitation of CLOCK and ERa was obtained when the same immunoprecipitation experiment was carried out using COS-7 cells transfected with Flag-tagged CLOCK and HA-tagged ERa (Figure 1b) . Moreover, the direct interaction of ERa and CLOCK was further confirmed using mammalian twohybrid system. Transactivation by pBIND-CLOCK was strongly activated by co-expressing a pACT-ERa fusion protein (Figure 1c) . Therefore, we speculated that CLOCK may work as a cofactor participating in the estrogen signaling pathway, and this would require the coexpression of ERa and CLOCK in the cell, particularly their colocalization in the cell nucleus. Double-label fluorescence immunohistochemistry aiming at detecting the localization of CLOCK and ERa in MCF-7 cells treated with or without E2 showed that after treatment with E2, much more CLOCK and ERa were colocalized in the nucleus (Figure 1d ). This suggested that CLOCK may directly participate in the estrogen signaling pathway.
The interaction between CLOCK and ERa was further investigated by luciferase reporter assay in MCF-7 cells. Overexpression of CLOCK alone had little effect on the level of ERE-luc activity compared with control. Overexpression of ERa alone without and with E2 treatment increased ERE-luc activity (Figure 1e ). However, overexpression of both ERa and CLOCK resulted in a further twofold increase of ERE-luc activity in the presence of E2 treatment. This response was consistent with CLOCK-stimulated ERa transcriptional activity in response to E2 treatment. Similarly, overexpression of ERa and SRC-1, which is a classical coactivator for ERa, also increased the level of ERE-luc activity, and repeated here as a positive control (Figure 1e) . Knockdown of CLOCK expression in MCF-7 cells using the specific small interfering RNA, siCLOCK-2467, suppressed ERa-mediated transcriptional activity while another specific small interfering RNA, siCLOCK-1357, showed almost no effect on the transcriptional activity of ERa. This was further confirmed by western blot analysis, which showed that siCLOCK-2467 effectively repressed the expression of CLOCK protein, whereas siCLOCK-1375 had no effect on its expression (Figure 1f ). The ability of CLOCK to regulate the expression of the well-established ERa-targeted gene, cyclin D1, was also examined. Knockdown of CLOCK by siCLOCK-2467 decreased the activity of cyclin D1 reporter and expression level of cyclin D1 (Figures 1g and h ). The data from these experiments provided support for the upregulation of ERa transcriptional activity by CLOCK in the presence of estrogen.
CLOCK is modified by SUMO-1 Previous research has shown that ERa interacts with several cofactors, such as members of the p160 family, and all known members of p160 family are subjected to sumoylation. [10] [11] [12] As CLOCK has a similar structure with members of the p160 family, we wished to know whether CLOCK is also a target of sumoylation. As shown in Figure 2a , immunoprecipitated CLOCK from MCF-7 cells was detected by anti-SUMO-1 antibody. The size of this band corresponded to that of SUMO-conjugated CLOCK, and its intensity increased with increasing E2 treatment time, although the total amount of CLOCK protein remained relatively unchanged. Sumoylation was further confirmed in COS-7 cells, when these cells were first transfected with Flag-tagged CLOCK and Myc-SUMO-1, followed by immunoprecipitation carried out with anti-Flag antibody and subsequent western blot analysis with anti-Myc antibody ( Figure 2b ).
Bioinformatic analysis of the CLOCK protein sequence revealed two putative sumoylation sites, K67 and K851, which are located at the bHLH/PAS and C-terminal domain, respectively ( Figure 2c ). The sumoylation sites of two members of the p160 family, SRC-1 and SRC-2, are also shown for comparison purpose. Replacement of either K67 or K851 with arginine (K67R or K851R mutant) resulted in decreased sumoylation for the mutant CLOCK compared with wild type (Figure 2d ), indicating that K67 and K851 were the sites of sumoylation for CLOCK. However, changing both lysine residues to arginine (2K/2R mutant) appeared to abolish sumoylation (Figure 2d ). To determine how much influence sumoylation exerts on the transcriptional activity of CLOCK, COS-7 cells were transfected with Gal4 promoter-driven luciferase (Gal4-Luc) construct along with GAL4-DBD or GAL4-DBD-CLOCK (wild type or mutant), and the luciferase activity was then measured. GAL4-DBD-CLOCK construct bearing wild-type CLOCK showed more luciferase activity than the construct bearing any of the three mutants ( Figure 2e ). These data showed that sumoylation of CLOCK was essential for maintaining a higher level of transcriptional activity.
Sumoylation of CLOCK is reversed by SENP1
Sumoylation is a dynamic process that can be reversed by sentrinspecific protease (SENP). There are three SENPs present in the cell nucleus, and these are referred to as SENP1, SENP2 and SENP3. [32] [33] [34] [35] To determine which of the three SENPs could reverse the sumoylation of CLOCK, COS-7 cells were transfected with Figure 1 . Evidences for the interaction between CLOCK and ERa. (a) MCF-7 cells were treated with 10 nM E2 after serum starvation for 48 h, and the cells were then collected at the indicated time points and subjected to immunoprecipitation with anti-CLOCK (or anti-ERa antibody) or control immunoglobulin G (IgG) followed by western blot analysis with anti-ERa (or anti-CLOCK) antibody. (b) COS-7 cells were transfected with Flag-tagged CLOCK and HA-tagged ERa. After 24 h of transfection, the cells were subjected to immunoprecipitation with anti-Flag antibody, followed by western blot analysis with anti-HA antibody. (c) Direct interaction between CLOCK and ERa as detected using a mammalian twohybrid system. CLOCK and ERa were expressed from pBIND-CLOCK and pACT-ERa, respectively, whereas the empty vectors pACT and pBIND were expressed as controls, as indicated with the pG5-luc reporter in COS-7 cells. Cells were transfected with pBIND-ID and pACT-MyoD as a positive control. Luciferase activity was measured after 36 h of transfection. **Po0.01 compared with cells transfected with pACT and pBIND. (d) Colocalization of ERa and CLOCK in MCF-7 nuclei. MCF-7 cells were treated with or without 10 nM E2 for 1 h before treatment with anti-CLOCK and anti-ERa antibodies. CLOCK-antibody complex was visualized with fluorescein isothiocyanate (FITC), whereas ERa-antibody complex was visualized with tetraethyl rhodamine isothiocyanate (TRITC). Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). (e) MCF-7 cells were co-transfected with ERE-luciferase construct (300 ng) and either with ERa or CLOCK, ERa and CLOCK or with ERa and SRC-1. Luciferase activity was measured either with or without pre-treatment of the cells with 10 nM E2 for 16 h. (f) MCF-7 cells were transfected with ERE-luciferase only or with ERa, or with ERa and siCLOCK constructs. Luciferase activity was measured either with or without pre-treatment of the cells with 10 nM E2 for 16 h. (g) MCF-7 and T47D cells were transfected with cyclin D1-luc only or together with ERa, or with ERa and siCLOCK constructs. The cells were treated without or with 10 nM E2 for 16 h before subjecting to reporter assay. (h) MCF-7 and T47D cells were transfected with ERa or ERa and siCLOCK constructs and then subjected to serum starvation for 48 h, followed by E2 or no E2 treatment for 4 h before analysis of cyclin D1 expression by real-time PCR. Cyclin D1 mRNA level was normalized with a glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA level. **Po0.01 and *Po0.05 compared with cells transfected with ERa only. Each bar represents the mean ± s.d. from three independent experiments. GAL4-DBD-CLOCK and either one of the three Flag-tagged SENPs, and the level of luciferase activity was measured. Only COS-7 cells co-transfected with CLOCK and SENP1 showed reduced level of reporter activity, about 50% compared with cells transfected with CLOCK alone (Figure 3a ). In contrast, the level of reporter activity in COS-7 cells co-transfected with CLOCK and either SEPN2 or SENP3 was similar to that of cells transfected with CLOCK alone. Thus, only SENP1 was able to reverse the sumoylation of CLOCK through its desumoylation activity. Mutant SENP1 (R630L/K631M), which lost its catalytic activity had no effect on the sumoylation of CLOCK. In all cases, the levels of CLOCK were similar as shown by western blot, consistent with the reduction of reporter activity being caused by the action of SENP1, which reflected the sumolyation status of CLOCK. In addition, the reduction of luciferase activity caused by SENP1 occurred in a dosagedependent manner (Figure 3b ). The amount of sumoylated CLOCK in cells transfected with wild-type SENP1 was reduced compared with that transfected with a mutant SENP1 (Figure 3c ), and this provided further support for the SENP1-mediated inhibition of CLOCK transcriptional activity through desumoylation.
Sumoylation of CLOCK influences its interaction with ERa
In the aforementioned experiment, treatment of MCF-7 cells with E2 promoted the association of CLOCK with ERa as well as the sumoylation of CLOCK (Figures 1a and 2a) . This suggested that the interaction between CLOCK and ERa may also be governed by the sumoylation of CLOCK. To demonstrate this, MCF-7 cells were transfected with Flag-tagged wild-type or the double mutant CLOCK 2K/2R, followed by immunoprecipitation and western blot analysis performed with anti-Flag antibody and anti-ERa antibody, respectively. ERa was detected only in the extract of cells overexpressing wild-type CLOCK, whereas cells overexpressing 2K/2R showed no detectable level of ERa (Figure 4a ), demonstrating the impact of sumoylation on the interaction between CLOCK and ERa, which was consistent with the fact that sumoylation of CLOCK promoted its interaction with ERa. In addition, the effect of CLOCK sumoylation on the interaction between CLOCK and ERa was also examined using nuclear and cytosolic extracts prepared from MCF-7 cells that had been treated without and with E2 for 30 min. The two extracts were first subjected to immunoprecipitation using anti-ERa antibody, and then to re-immunoprecipitation using anti-CLOCK antibody, followed by western blot with anti-SUMO-1 antibody. As shown in Figure 4b , a single band was detected by anti-SUMO-1 antibody, and only for the nuclear extract. This band was attributed to SUMO-CLOCK, which appeared to be much more intense after the cells had been treated with E2. This result suggested that interaction between CLOCK and ERa was restricted to the nucleus, and further confirmed the promotion of CLOCK sumoylation by estrogen. Sumoylation of CLOCK has a role in ER signaling Sumoylation of CLOCK regulated its transcriptional activity and its association with ERa. To determine whether sumoylation of CLOCK also affects the transcriptional activity of ERa, MCF-7 cells were co-transfected with ERE-luciferase and ERa only, or EREluciferase, ERa and wild-type or mutant CLOCK, and the levels of reporter activity for these cells were determined after subjecting to E2 or no E2 treatment. As expected, luciferase activity was highest for E2-treated cells that overexpressed both ERa and wildtype CLOCK (Figure 5a) . Overexpression of the double mutant CLOCK and ERa resulted in as much as 35% drop in reporter activity compared with overexpression of ERa alone in the presence of E2 treatment, and this may due to interference of endogenous CLOCK activity (that was associated with ERa) by mutant CLOCK, which appeared to interfere the transcriptional activity of ERa. Nevertheless, the result did show that activation of ER-mediated signaling by CLOCK closely associated with the sumoylation of CLOCK.
Cyclin D1 is known to promote the proliferation of MCF-7 cells. 36 MCF-7 cells co-transfected with ERa, cyclin D1-luciferase and wild-type CLOCK showed the highest level of luciferase activity in the presence of E2 treatment (Figure 5b) . Furthermore, the double mutant CLOCK appeared to have no effect on cyclin-D1-luciferase activity, either with or without E2 treatment. Similar result was also obtained for real-time PCR analysis, where a higher level of cyclin D1 mRNA was observed for cells transfected with wild-type CLOCK than the double mutant CLOCK in the presence of E2 treatment (Figure 5c ). In all three experiments, no difference was detected among the cells overexpressing ERa only or together with wild-type or mutant CLOCK in the absence of E2 treatment.
Effect of CLOCK sumoylation on MCF-7 cell proliferation
The effect exerted by sumoylation of CLOCK on the growth of MCF-7 and T47D cells was examined. Consistent with higher transcription levels of cyclin D1, cells overexpressed wild-type CLOCK showed more growth than cells that overexpressed the double mutant CLOCK 2K/2R in the presence of E2 treatment (Figure 6a) , suggesting that the proliferation of these cells was subjected to regulation by CLOCK-modulated transcription factors, including ERa, whose activity is known to influence the proliferation of breast cancer cells. Furthermore, the regulation of these transcription factors by CLOCK was also dependent on the sumoylation status of CLOCK. To further examine whether the effect of the sumoylation status of CLOCK on the proliferation 1a). Cytosolic and nuclear fractions of the cell extract were prepared and subjected to immunoprecipitation with anti-ERa antibody and then to re-immunoprecipitation (Re-IP) with anti-CLOCK antibody, followed by western blot analysis with anti-SUMO-1 antibody.
MCF-7 cells would manifest through its effect on the cell cycle, cells transfected with either wild-type or mutant CLOCK 2K/2R were subjected to flow cytometry analysis to evaluate the cell cycle profile of asynchronous cells. Overexpression of wild-type CLOCK resulted in an overall increase in the percentage of S phase cells, with a corresponding reduction in the percentage of cells in G0/G1 phase compared with control cells (Figure 6b ). Overexpression of 2K/2R had little effect on the cell cycle. Thus, sumoylation of CLOCK not only increased cell proliferation through regulating other transcription factors, but also had a direct effect on the cell cycle by maintaining a greater percentage of the cell in the S phase.
DISCUSSION
Although more and more studies have indicated a connection between the disruption of the circadian rhythm and tumorigenesis, especially hormone-related tumorigenesis such as the development of breast cancer, it is not known whether CLOCK is directly involved in the modulation of such process. CLOCK works as a core transcription factor that has a crucial role in the regulation of circadian rhythm. However, CLOCK also regulates the expression of several non-circadian proteins, such as AhR and Cyp1a1. 23, 37 In this study, we demonstrated that in the human breast cancer cell line, CLOCK participated in the estrogen signaling pathway through acting as a regulator of ERa, and that this interaction between CLOCK and ERa was stimulated by E2. A possible mechanism whereby CLOCK may regulate ERa is through enhancing ERa-mediated transactivation activity, and E2 appeared to reinforce this effect.
In estrogen-mediated signaling, E2 exerts its effects through the ERs, ERa and ERb. Cai et al. 38 identified a novel way in which estrogen signaling is regulated by demonstrating that ERb is subjected to control by circadian clock proteins, and that this regulation is important for determining the cellular response to estrogens. Our data showed that the transcriptional activity of CLOCK also responded to the presence of estrogen, and it is reasonable to suggest that CLOCK is also involved in the estrogen signaling pathway through interacting with ERa. In MCF-7 cells, stimulation with E2 can promote this interaction within 30 min (Figure 1a) . According to the classical estrogen pathway, E2 induces the formation of a classical genomic ER-ERE complex that then activates the expressions of estrogen-dependent genes. In this process, ER recruits several transcription cofactors, such as members of the p160 family, CARM1 and p300 to regulate the expression of downstream genes. [39] [40] [41] BMAL1 may also take part in this process, as coexpression of CLOCK and BMAL1 promoted this activation effect (data not shown).
Many proteins involved in transcription are subjected to sumoylation, which either activate or inhibit their activities, or change their subcellular locations, and these will in turn lead to changes in the statuses of the proteins they regulate. 42, 43 In this study, we showed that CLOCK can be sumoylated, and identified two sumoylation sites, K67 and K851. Sumoylation of CLOCK was promoted by E2 treatment. Sumoylation of CLOCK was important for its regulation of ERa transcriptional activity, as MCF-7 cells overexpressing the double mutant CLOCK 2K/2R (which had lost both sumoylation sites) had reduced level of ERa-controlled reporter gene activity compared with MCF-7 cells overexpressing wild-type CLOCK (Figure 5a ). The expression of either wild-type CLOCK or 2K/2R did not change the overall expression of ERa (data not shown). Therefore, the observed enhancement in ERa activity was not due to increased level of ERa protein, and may possibly be the result of the interaction that occurred between ERa and CLOCK, especially sumoylated CLOCK, the status of which was also confirmed by SENP1, which effectively reversed the sumoylation process.
The attachment of SUMO to a protein often causes a change in the conformation of the protein, thereby affecting its association with other proteins. The sumoylation sites of CLOCK were located in the bHLH/PAS (K67) and C-terminal (K851) regions. Analysis of the primary structure of CLOCK in different species of organisms showed that K67 and K851 are conserved residues. SRC-1, a classic coactivator of ER and progesterone receptor, is sumoylated at K732 and K774, and both sites are located in the protein-protein interaction domain. SRC-1 that has lost both sumoylation sites has markedly reduced interaction with progesterone receptor, suggesting that the extent of sumoylation of SRC-1 has a role in receptor-coactivator interaction. As for SRC-2, one of its sumoylation sites, K239, is also located in the bHLH/PAS domain, and mutant form of SRC-2 in which this K239 has been replaced with arginine has decreased transactivation activity. 10 Similarly, K67 of CLOCK is located in the region that mediates CLOCK's association with other proteins, such as BMAL1, PER1 and CRY1, and this interaction may be affected by the loss of sumoylation at K67 as demonstrated by the loss of transcriptional activity for the K67R mutant. K851 lies almost at the C-terminal end of CLOCK, similar to the location of K1378 of SRC-1 (see Figure 2c) . K1378 is another sumoylation site of SRC-1, and sumoylation of SRC-1 at this site also enhances its transactivation activity. 12 Although sumoylation at K851 of CLOCK also exerted a moderate effect on the activity of CLOCK, and hence, on the interaction between CLOCK with ERa and possibly other proteins, it is unlikely that protein-protein interaction is a key factor controlled by sumoylation at this site. Sumoylation of CLOCK altered the level of ERa transcriptional activity probably through enhancing its binding with ERa (Figure 4a ). In the case of cyclin D1 expression, wild-type CLOCK increased its expression by 40% in the presence of E2 treatment, but no change was observed for the mutant CLOCK 2K/2R (Figure 5b ). These data suggested that change in the expression of cyclin D1 was induced through ERa, which can be regulated by sumoylated CLOCK. However, whether sumoylation of CLOCK has a direct effect on the expression of cyclin D1 or other proteins involved in E2 signaling pathway remain to be determined.
ER-positive breast cancers generally have a better prognosis and are often responsive to anti-estrogen therapy, which is the first example of a successful therapy that targets a nuclear receptor, ER. 44 Unfortunately ER-negative breast cancers are more aggressive and unresponsive to anti-estrogens. 45 Hoffman et al. 16 found that patients with ER-negative tumors had even higher levels of CLOCK expression than patients with ER-positive tumors.
It appears that the expression of CLOCK is positively correlated with the malignancy of breast cancer. In this study, the transcriptional activity of ERa and the growth of the two breast cancer cells, MCF-7 and T47D, promoted by CLOCK were E2 dependent, as cell lines are ERa-positive cell lines. This may suggest that stimulation of ERa by CLOCK may represent an important mechanism for the growth of ER-positive breast cancer.
As for the higher level of CLOCK observed for ERa-negative tumors previously reported, 16 there may exist another unknown pathway participated by CLOCK, which has yet to be determined.
A number of tumors related to the action of hormone are closely associated with a disorder of circadian rhythm. Although we have shown here that CLOCK can work as a coactivator in ER signaling pathway and sumoylation of CLOCK had crucial roles in this progress, the exact mechanism pertaining to the nature of the circadian rhythm is unknown. Elucidating the relationship between clock proteins and ER network will further uncover the molecular mechanism between circadian disruption and breast cancer, and this may provide better insight for conceiving a way to combat cancers based on the manipulation of CLOCK-ERamediated signaling pathway.
MATERIALS AND METHODS

Plasmids and antibodies
Rabbit polyclonal anti-Gal4-DBD, anti-Flag, anti-CLOCK, anti-ERa and antiMyc antibodies and mouse monoclonal anti-Gal4-DBD and anti-SUMO-1 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Goat polyclonal anti-CLOCK antibody was obtained from Santa Cruz Biotechnology. Mouse monoclonal anti-Flag antibody (M2) was purchased from Sigma (St Louis, MO, USA).
CLOCK mutants (K67R, K851R and K67R/K851R) were generated using a site-directed mutagenesis kit according to the manufacturer's instructions (Stratagene, La Jolla, CA, USA). Flag-tagged CLOCK (wild type and mutants) were amplified by PCR and subcloned into 3 Â Flag-pCMV10 vector at the HindIII and BamHI sites.
Cell culture, reporter assays and small interfering RNA constructs
The human breast cancer cell line MCF-7 and African green monkey kidney cell line COS-7 had been used in our previous study. 11 They were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Auckland, New Zeeland) containing 10% fetal bovine serum (Hyclone, Beijing, China). As for T47D cells, it was maintained in RPMI-1640 medium (Invitrogen) supplemented with 0.2 U/ml insulin and 10% fetal bovine serum. Cells were plated in 24-well plates and transfected with the appropriate plasmid construct using Lipofectamine 2000 (Invitrogen) according to the manufacturer's specification. Five hours after transfection, the medium was replaced with phenol red-free medium containing 10% charcoaldextran-treated fetal bovine serum for 48 h, followed by treatment with or without 10 nM 17b-estradiol (E2) for 16 h. Cells were then subjected to luciferase and Renilla activity assays using a dual luciferase kit (Promega, Madison, WI, USA).
The following sequences, representing 19-bp stretches of the CLOCK mRNA were present in the hairpin transcripts: siCLOCK-1375, 5 0 -T TTGCCTTTTCCATATTGC-3 0 ; siCLOCK-2467, 5 0 -AAATCTTATCTGTCTGTCC-3 0 . SiCLOCK vectors were constructed as previously described. 46, 47 SiCLOCK-1375 construct showed no suppression of CLOCK protein and was used as a control.
Western blot, immunoprecipitation and immunofluorescence
Proteins from cells were harvested. Western blot, immunoprecipitation and re-immunoprecipitation were conducted as previously described. 31, 48 For immunofluorescence analysis, MCF-7 cells were first plated on coverslips and incubated for overnight. The cells were then subjected to serum starvation for 24 h followed by treatment with E2 for 1 h. Immunofluorescence analysis was performed as previously described. 31 Images were taken using confocal fluorescence microscope (Olympus FV1000-IX81, Tokyo, Japan).
Mammalian two hybrid assay
The checkmateTM mammalian two-hybrid system was obtained from Promega. ERa and CLOCK were subcloned into BamHI-SalI cut pACT and pBIND, respectively.
Cell proliferation assays
Cell proliferation assay was performed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. MCF-7 and T47D cells were stably transfected with control vector or Flag-CLOCK (wild type or mutant). Cells were incubated in phenol red-free Dulbecco's modified Eagle's medium supplemented with 10% charcoal-dextran-treated fetal bovine serum for 24 h before treatment with vehicle or 10 nM E2 for several days. After that, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed according to the manufacturer's protocol (Key Gen, Nanjing, China). The absorbance of the sample was read at 490 nm and the values were normalized and plotted as percentage of control cells. For cell cycle analysis, MCF-7 cells transfected with the indicated vectors were grown in the presence of 10 nM 17b-estradiol (E2) for 36 h, and then fixed in cold water-free ethanol overnight at À 20 1C, and then stained with propidium iodide (Sigma) for 15 min before subjecting to flow cytometry. Cell cycle profiles were determined using ModFit LT (BD Biosciences, San Jose, CA, USA).
Real-time reverse transcriptase-PCR MCF-7 cells were starved for 48 h and then treated with 10 nM E2 for 4 h before they were harvested. Total RNA was extracted from the cells using Takara RNAiso Reagent (Takara, Dalian, China). The cyclin D1 and glyceraldehyde 3-phosphate dehydrogenase (as an internal control) mRNA levels were quantitated by real-time PCR using Corbett Research RG 3000 analyzer (Australia), RealMasterMix (SYBR Green; Tiangen Biotech, Beijing, China). The primers for cyclin D1 mRNA were 5 0 -GCTGCTCCTGGTGAA-CAAGC-3 0 (forward) and 5 0 -AAGTGTTCAATGAAATCGTGCG-3 0 (reverse), and for glyceraldehyde 3-phosphate dehydrogenase were 5 0 -GGGTGTGAACC ATGAGAAGT-3 0 (forward) and 5 0 -GACTGTGGTCATGAGTCCT-3 0 (reverse). The mRNA level of cyclin D1 was normalized to glyceraldehyde 3-phosphate dehydrogenase as the endogenous control. Each target was measured in triplicate.
All statistical analyses of data were preformed with analysis of variance method. Data are given as mean±s.d., and significance was considered at either P-value o0.05 or 0.01 level.
